ARTICLE | Company News
FDA issues handful of new PDUFA dates
February 19, 2019 10:39 PM UTC
With the government shutdown resolved, FDA has accepted a handful of applications for review, according to company announcements early this week.
FDA granted Priority Review to two applications from Genentech Inc. for entrectinib and polatuzumab vedotin...